Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 4 results found. Search for [ Covaxin trail ]

Results 1 to 4 of 4
Rashi Bisaria
New Delhi, October 15, 2020
COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


BusinessToday.In
July 20, 2020
COVAXIN is the first indigenous coronavirus vaccine, being developed by Hyderabad-based Bharat Biotech and Indian Council of Medical Research (ICMR). AIIMS, Delhi is one of the 12 facilities shortlisted by ICMR for conducting clinical trials of Covaxin


E Kumar Sharma
July 18, 2020
COVAXIN, the country's first possible vaccine against COVID-19, will be tested on 1,125 healthy volunteers in two phases (phase 1 and 2)


PAGES 1 OF 1